← Companies
Sponsor / Institution
James Baumgartner, MD
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs
2
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
2
0 open data checks
Company / Institution Links
0 / 2
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
0
Completion Signal
0
Programs by Stage
Phase 1/22
Trial / Program Status
Completed1
Paused1
Modality Mix
Cell Therapy2
Indication Coverage
Hearing Loss2
Sensorineural Hearing Loss2
Program Types
Therapeutic2
Population Tags
pediatric2
sensorineural2
cell-therapy1
study-level1
Strong-Evidence Records
0 recordsNo strong-evidence records are linked to this organization yet.
Checked Records With Caveats
2 checked · 0 open checksAutologous Cord Blood Stem Cell Infusion Study for Pediatric Acquired Hearing Loss
Details checked
Cell TherapyPhase 1/2Completed
Phase 1/2 safety study of a single intravenous infusion of autologous human umbilical cord blood cells in children with acquired sensorineural hearing loss.
Data checks: investigator-led-study, registry-only-evidence
Autologous Bone Marrow Infusion Study for Sensorineural Hearing Loss
Details checked
Cell TherapyPhase 1/2Paused
Single-arm investigator-led study of intravenous autologous bone marrow mononuclear cells harvested from the patient and infused for pediatric sensorineural hearing loss.
Data checks: investigator-led-study, registry-verified-study